Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2001 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Bioelectric stimulation and residual ridge resorption.
Ortman LF, Casey DM, Deers M. Ortman LF, et al. Among authors: casey dm. J Prosthet Dent. 1992 Jan;67(1):67-71. doi: 10.1016/0022-3913(92)90052-c. J Prosthet Dent. 1992. PMID: 1548612
The use of exogenous pulsed electromagnetic fields (PEMF) to stimulate the healing of nonunions and other long bone defects is common in medicine. This investigation used the dog model and image analysis of standardized radiographs to assess loss of residual ridge height f …
The use of exogenous pulsed electromagnetic fields (PEMF) to stimulate the healing of nonunions and other long bone defects is common …
Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM, Casey DB, Smith WG, Vigneulle RM, McKearn JP, MacVittie TJ. Farese AM, et al. Among authors: casey db. Stem Cells. 2001;19(6):522-33. doi: 10.1634/stemcells.19-6-522. Stem Cells. 2001. PMID: 11713344
Other cohorts received G-CSF (Neupogen((R)) [Filgrastim]) in an every-other-day schedule at 100 microg/kg/day, or autologous serum (0.1%) s.c. daily. Hematopoietic recovery was assessed by bone marrow clonogenic activity, peripheral blood cell nadirs, duration of cy …
Other cohorts received G-CSF (Neupogen((R)) [Filgrastim]) in an every-other-day schedule at 100 microg/kg/day, or autologous serum (0.1%) s. …